Do incretin-based therapies cause acute pancreatitis?

Journal of Diabetes Science and Technology

Volumn 4, Issue 1, 2010, Pages 228-229

  Olansky, Leann ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Exenatide; Gallbladder disease; Incretin; Pancreatitis; Sitagliptin; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INCRETIN;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; EVALUATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREATITIS; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; PANCREATITIS; RISK FACTORS; YOUNG ADULT;

EID: 77954671985     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400129     Document Type: Note

References (9)

1. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39(8):709-16.
2. Blomgren KB, Steineck G, Sundstrom A, Wiholm BE. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care. 2002;25(2):298-302.
3. Forsmark CE, Baillie J; AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA institute technical review on acute pancreatitis. Gastroenterology. 2007;132(5):2022-44.
4. Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigolon A, Peracchi M, Conte D. Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis. 2004;36(2):130-4.
5. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161(13):1581-6.
6. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, Benini L, Vantini I, Corrocher R, Puccetti A. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;361(22):2135-42.
7. Noel RA, Patterson RE, Braun DK, Bloomgren GL. Increased risk for acute pancreatitis and biliary disease observed in patients with type 2 diabetes. Diabetes Care. 2009;32(5):834-38.
8. Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med. 2006;354(20):2142-50.
9. Dore DD, Seeger JD, Arnold Chan K. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin. 2009;25(4):1019-27.